Trial Profile
Efficacy of pegylated interferon alfa-2a (PegIFN) with add on treatment with nucleot(s)ide analogue, tenofovir, in chronic hepatitis B patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Therapeutic Use
- 10 Aug 2015 New trial record